HIV mRNA Vaccine2022-06-10T06:18:25+00:00

HIV (human immunodeficiency virus) is a virus that attacks the body’s immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome).

About HIV

Learning the basics about HIV can keep you healthy and prevent HIV transmission.

Source: CDC

From an epidemiological standpoint, there were an estimated 37.7 million [30.2–45.1 million] people living with HIV at the end of 2020, over two thirds of whom (25.4 million) are in the WHO African Region. In 2020, 680 000 [480 000–1.0 million] people died from HIV-related causes and 1.5 million [1.0–2.0 million] people acquired HIV.

Source: WHO

HIV mRNA Vaccine Pipeline

DEVELOPMENT

PRECLINCAL

PHASE 1

PHASE 2

PHASE 3

INDICATION
HIV mRNA Vaccine (HIV-mRNA)

GLOBAL PUBLIC HEALTH IMPACT
Prophylactic mRNA Vaccine. Therapeutic mRNA Vaccine

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Normax

LICENSING
Vaxcomm

HIV mRNA Vaccine Pipeline

DEVELOPMENT

INDICATION
HIV mRNA Vaccine

TECHNOLOGY
Prophylactic mRNA Vaccine. Therapeutic mRNA Vaccine

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Normax

LICENSING
Vaxcomm

Pricing

Our goal is to be able to mass-produce a vaccine that is both highly efficient and affordable for the general public, that we will be able to distribute at the cost of only $4 per dose.

According to JAMA, the treatment of HIV costs between $36 080 to $48 000 (2018) per patient, per year, in the U.S.

Go to Top